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Abstract: M etabolic stress, such as lipotoxicity, affects the D N A  m ethylation profile in pancreatic 
p-cells and thus contributes to p-cell failure and the progression of type 2 diabetes (T2D). 
Stearoyl-C oA  desaturase 1 (SCD 1) is a rate-lim iting enzym e that is involved in  m onounsaturated 
fatty acid synthesis, w hich  protects pancreatic p -cells against lipotoxicity. The present study 
found that SCD1 is also required for the establishm ent and m aintenance of D N A  m ethylation 
patterns in p-cells. We show ed that SCD1 inhibition/deficiency caused D N A  hypom ethylation 
and changed the m ethyl group distribution w ith in  chrom osom es in p-cells. Low er levels of D N A  
m ethylation in SC D 1-deficient p-cells w ere follow ed by  low er levels o f D N A  m ethyltransferase 
1 (D N M T1). We also found that the dow nregulation of SCD1 in pancreatic p-cells led to the 
activation of adenosine m onophosphate-activated  protein kinase (A M PK ) and an increase in the 
activity of the N A D -dependent deacetylase sirtuin-1 (SIRT1). Furtherm ore, the physical association 
betw een D N M T1 and SIRT1 stim ulated the deacetylation of D N M T1 under conditions of SCD1 
inhibition/downregulation, suggesting a m echanism  by w hich  SCD1 exerts control over D N M T1. 
We also found that SCD1-deficient p-cells that were treated w ith compound c, an inhibitor of AM PK, 
were characterized by higher levels of both global DNA m ethylation and DNMT1 protein expression 
com pared w ith  untreated cells. Therefore, w e found that activation of the AMPK/SIRT1 signaling 
pathway m ediates the effect of SCD1 inhibition/deficiency on DNA m ethylation status in pancreatic 
p-cells. A ltogether, these findings suggest that SCD1 is a gatekeeper that protects p-cells against 
the lipid-derived loss of D N A m ethylation and provide m echanistic insights into the m echanism  by 
w hich SC D 1 regulates D N A  m ethylation patterns in p -cells and T2D -relevant tissues.
Keywords: SC D 1; D N A m ethylation; A M PK; epigenetic regulation; lipotoxicity
1. Introduction
The em ergence of type 2 diabetes (T2D) as a global pandem ic is a m ajor issue. The tw o central
abnorm alities that characterize the pathophysiology of T2D  are insulin resistance in peripheral tissues
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and the progressive loss of p-cell function in pancreatic islets [1- 3 ]. A ccum ulating evidence indicates 
that epigenetic m odifications, genetic background, environm ental factors, and the dysregulation of 
lipid hom eostasis are prim ary reasons underlying p-cell dysfunction and T2D developm ent [2].
D N A  m ethylation and other epigenetic alterations, such as histone m ethylation and acetylation, 
regulate gene expression and are crucial for m aintaining genomic integrity and chrom osom e structure. 
D N A  m ethylation is a chem ical post-replicative m odification w hereby a m ethyl group (-C H 3 ) is 
covalently added to the fifth carbon of the cytosine ring of 5'-to-3'-oriented  CG dinucleotides, w hich are 
know n as C pG  sites [4]. R egions w ith  a h igh frequency of C pG  sites are often  found in  gene 
prom oters. C ytosine m ethylation w ithin  the prom oter region is know n to inversely  correlate w ith  
expression of the gene by  affecting the binding of transcription factors and m ethylcytosine-binding 
proteins to the DNA and heterochrom atin form ation [5 ]. In m am m als, DNA m ethylation patterns are 
generated and m aintained by  a fam ily  of D N A  m ethyltransferases (DNM Ts). This process is highly 
dependent on  the availability  o f S-adenosyl m ethionine (SA M ), a prim ary m ethyl group donor [6 ]. 
D N M T1 is the m ost abundant D N A  m ethyltransferase in adult som atic cells and regarded as a 
m aintenance m ethyltransferase. D N M T1 preferentially catalyzes the addition of the -CH 3  group to the 
hem i-m ethylated DNA strand during the S-phase of replication [7]. However, the significant capacity 
of D N M T1 for de novo m ethylation w as also reported [8 ].  D N M T1 activity  and protein stability 
are highly regulated by  various post-translational m odifications, such as acety lation , m ethylation, 
and ubiquitination— through interactions with other epigenetic effectors, such as the NAD-dependent 
deacetylase sirtuin-1 (SIRT1) [9,10].
The establishm ent and preservation of D N A  m ethylation patterns along the genom e are 
critically im portant for both pancreatic organogenesis and m ature p-cell function and survival [1 1 , 1 2 ]. 
A w hole-genom e bisulfite sequencing study identified 25,820 differentially methylated regions (DMRs) 
and 457 genes that presented both D M Rs and significant changes in expression in pancreatic islets from 
T2D donors, including loci w ith a key function in islet biology (e.g., PDX1, A D CY5, and SLC2A2) [13]. 
D N M T1-deficient pancreatic p-cells w ere deprived of their epigenetic constraints and converted into 
a-cells through hypom ethylation of the A R X  prom oter region [11]. Evidence show s that changes in 
DNA m ethylation are also part of the functional adaptation of p -cells to lipotoxicity that is related to T 2 D 
pathogenesis [14] . Pancreatic islets that w ere exposed to palm itic acid (16:0) exhibited dysregulation 
of D N A  m ethylation and changes in expression of genes that are involved in insulin signaling, lipid 
m etabolism , and energy hom eostasis [14].
Stearoyl-CoA desaturase 1 (SCD1) is a pivotal enzyme that is involved in palmitic acid metabolism 
and has a protective action against lipotoxicity in p-cells [15,16]. SCD1 catalyzes insertion of the double 
bond at the delta-9 position of 12-19 carbon in saturated fatty acids (SFAs; preferentially palmitate (16:0) 
and stearate (18:0)), thereby converting them  to m onounsaturated fatty  acids (M UFAs; palm itoleate 
(16:1n-7) and oleate (18:1n-9)) [16]. Long-chain  SFAs are reportedly m ore cytotoxic than long-chain  
MUFAs. SCD1 activity has crucial physiological im portance for proper p-cell function, and its ablation 
is associated w ith  p-cell failure and T2D  developm ent [15,17,18]. SCD1 deficiency results in low er 
glucose-stimulated insulin secretion, proliferation, and apoptosis induction in p-cells [19]. Furthermore, 
the inhibition of SCD1 activity affects autophagosom e-lysosom e fusion through perturbations in cellular 
m embrane integrity, leading to an aberrant stress response and p-cell failure [19]. Our previous studies 
dem onstrated the w ell-established role of SCD1 in the control of intracellular SFA/MUFA equilibrium  
and show ed that SCD1 is also involved in epigenetic regulation [20,21]. The inhibition of SCD1 w as 
show n to alter D N A  m ethylation levels in 3T3-L1 adipocytes [21]. Additionally, SCD1 expression 
affects the global acety lation and m ethylation levels of lysine 9 on histone H 3 through an increase 
in the activity of adenosine m onophosphate-activated protein kinase (A M PK ) and SIRT1 in  skeletal 
muscle [20]. However, to our knowledge, no study has evaluated the orchestration of epigenetic events 
by  SC D 1  in pancreatic islets.
C onsidering the possible interplay betw een SC D 1  and epigenetic regulation, w e investigated the 
role of SCD1 in m aintaining the D N A  m ethylation profile in pancreatic p-cells. We found that SCD1
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inhibition/gene silencing altered the distribution of -CH 3  groups w ithin chromosomes and elicited DNA 
hypom ethylation in p-cells. These effects appeared to be m ediated by the AM PK/SIRT1-dependent 
downregulation of DNM T1.
2. Results
2.1. SCD1 Deficiency Is A ssociated with a Decrease in gD N A  M ethylation Levels in Pancreatic fi-Cells
The level of global DNA (gDNA) methylation in pancreatic islets that were isolated from SCD1-/- 
m ice significantly decreased by  40%  com pared w ith  W T islets (Figure 1A ). To investigate the effect 
of SCD1 on the regulation of D N A  m ethylation patterns in  pancreatic IN S-1E cells, w e transfected 
INS-1E cells w ith specific siRNA, w hich decreased SCD1 m RN A levels by ~90% (Figure 1B) and SCD1 
protein levels by >60%  (Figure 1C ). We also decreased SCD1 activity in INS-1E cells using the selective 
pharm acological inhibitor A 939572. The cells w ere incubated w ith  palm itate (16:0), w hich  has been 
show n to augm ent the severity of the SCD1 deficiency-related stress response in  insulin-secreting 
M IN 6  cells [22]. Both SCD1 inhibition and the genetic ablation of SCD1 by siRN A  decreased gD N A  
m ethylation levels by  ~40%  com pared w ith  control cells (Figure 1D ,E). The treatm ent of IN S-1E 
cells w ith  palm itate itself did not significantly affect gD N A  m ethylation levels. H ow ever, gD N A  
m ethylation levels in  SC D 1-deficient IN S-1E cells that w ere incubated w ith  palm itate decreased by 
nearly  60%  com pared w ith  controls and w ere higher than in cells that w ere treated w ith  the SCD1 
inhibitor, or siRN A against SCD1 alone (Figure 1D ,E).
We also evaluated the effect of SCD1 inhibition on gDNA m ethylation levels based on spectroscopic 
R am an analysis. We first analyzed the average R am an spectrum  of D N A  that w as isolated from  
INS-1E cells. The Raman spectrum contained bands that were characteristic of the stretching of bonds 
between phosphate and oxygen atoms in the DNA backbone at 1250 cm - 1  (uasym(OPO)) and 1090 cm - 1  
(usym(OPO )) and bands that w ere characteristic of -C H 3  group vibrations at 2975 cm - 1  (uasym(C H 3 )) 
and 2890 cm - 1  (usym(CH 3 ); Figure 1F). We then integrated the band in the spectral range of 2920-2870 
cm - 1 , w hich  reflected the quantitative am ount of -C H 3  groups in D N A  from  control IN S-1E cells, 
and cells that were treated w ith the SCD1 inhibitor. Consistent with the enzymatic results, the inhibition 
of SCD1 activity led to the loss of -CH 3  groups in DNA and a reduction in gDNA methylation levels in 
IN S-1E cells com pared w ith controls (Figure 1G ).
2.2. Inhibition ofSC D 1 A ctivity Leads to Changes in M ethyl Group Distribution within Chromosomes in 
Pancreatic fi-Cells
To further assess the role of SCD1 in the control of D N A m ethylation, w e estim ated the effect of 
SCD1 inhibition on -C H 3  group distribution w ithin  single chrom osom e 1 from  IN S-1E cells. U sing 
Em pty m odeling analysis, w e obtained average R am an spectra of single chrom osom e 1  that w ere 
collected from  control and SCD1 inhibitor-treated IN S-1E cells (Figure 2 A ). Based on  the integrity 
of the band in the spectral range of 2900 -2850  cm - 1 , w e estim ated that SCD1 inhibition decreased 
m ethylation levels in chrom osom e 1 in IN S-1E cells by  ~26% com pared w ith control cells (Figure 2B ).
To characterize the m orphology of m etaphase chrom osom es, w e perform ed atom ic force 
m icroscopy (A FM ) topographic im aging. W e analyzed the spatial distribution of the integrated 
band characteristic of the stretching of bonds betw een phosphate and oxygen atom s in the D N A  
backbone in the spectral range of 1280-1215 cm - 1  (uasym(OPO)), which refers to the DNA distribution, 
and the am ide I band in  the spectral range of 1695-1630 cm - 1 , that conform s to the distribution of 
proteins (m ainly histones). We also investigated the spatial distribution of the integrated band in 
the spectral range of 2900-2850  cm - 1  (usym(C H 3 )) that corresponded to the arrangem ent of -C H 3  
groups [23,24] . The distribution of proteins and D N A  w ithin  the chrom osom es w as sim ilar in  the 
SCD1 inhibitor-treated and control sam ples (Figure 2C ). Interestingly, w e found that the inhibition of 
SCD1 activity in IN S-1E cells affected the spatial spreading and location of -CH 3  groups over an area 
of chrom osom e 1. The m ain difference betw een the distribution of -CH 3  groups w ithin chrom osom e
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1— that w as isolated from  control IN S-1E cells and IN S-1E cells that w ere treated w ith  the SCD1 
inhibitor— w as related to hom ogeneity  (Figure 2C ). In  the case of chrom osom e 1 from  control cells, 
the -C H 3  group distribution w as heterogeneous, and the level of m ethylation w as the highest in the 
region of the p arm  and centrom ere o f the chrom osom e. The -C H 3  group distribution w as m ore 
hom ogeneous w ith in  chrom osom e 1 from  IN S-1E cells that w ere treated w ith  the SCD1 inhibitor 
com p ared w ith  controls (Figure 2C).
Figure; 1. Stearoyl-CoA desaturase 1 (SCD1) downregulation leads to global DNA (gDNA) 
hypomethylation in pancreatic islets and INS-1E cells. (At) gDNA methylation level in pancreatic islets 
that were isolated from wild type (WT) and SCD1-/- mice;, n = (5. * p <0.05, vs. WT. (B,C) Measurement 
of SCD1 silencing (siSCD1) efficienny lay analyzing SCD1 mRNA levels lay real-time PCR (B) and 
Western blot (C). (D,E) gDNA methylation level in INS-1 E cells )hat -were treated with the SCD1 
inhibitor A939572 (SCD1i) (D) or an siRNA against SCD1 (siSCD1) (E) and palmitic acid (1 6:0). gDNA 
methylation levels were evaluated by HpaIIgMspI digestion. (F) Average Raman spectrum of DINA that 
was isolated from 0NS-1E calls (average of 40 spectra). (G) The estimation of gDNA methylation levels, 
based on Raman sp ectroscopic analysis, in control andA939572-treated INS-1E c ells is presented as an 
average integration value (n = 10) oIthe band in the spectral range of 2920-21870 cm- 1  (us y m (CH3 )), 
corresponding to the distribu(ion of -CH3  groups and notmalized to the; band in the spectral range 
of 1110-1030 cm- 1  (i>s y m (OPO)), corresponding tea tire distribution of DNA. The data are expressed 
as mean ± SD. * p < 0.01s, ** p < 0.005, vs. vehicle/siCtrl; # p < 0.05, ## p < 0.005 vs. 16>:0r( 6:0 siCtrl; 
& p < 0.05, vs. siSCD1. The data are expressed as the mean ± SD of three independent experiments.
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Figure 2. Raman spectroscopic analysis of the effect of SCD1 inhibition on the spatial distribution of -CH3  
groupswithin single chromosome 1 in INS-1E cells. (-1) Average Raman spectrum cf chromosomes 
1 (n = 15, spectra obtained using empty modeling analysis) that were isolated from INS-1E cells 
(smoothed, Savitzky-Golay filter, second order, 11 pt). (B) Esiimation of global methylation levels in 
single chromosome 1 fro nr control INS-1 E cells and sells that were treated -with the SCD1 inhibitor, 
p resen ted as an ave rage inte.ration value (n a  6) of tha band in the spectral range of 2900-2850 cm- 1 
(us ym (CH3 )), corresponding to the distribution of -CH3  groups and normalized to the band in the 
spectral range of 1110-r070 cm- 1  (its y m (OPO)), corresponding to the dis(ribution of DNA. (C) Atomic 
iorce microscopy (AFM) ond Raman spectroscopic maps of chromosome r—isolated from INS-1 E 
cells, rhowing the topography of single chromosome 1 and the spatial distribution of integrated bands, 
borresponding to the distribution of DNA, proteins (mainly histones), arid methyl groups. tdie data are 
expressed as mean ± SD. * p < 0.01 , vs. vehicle.
2.3. A blation o fS C D 1 A ctivity and Expression Decreases DNM T1 Protein Levels in Pancreatic fi-Cells
To (urther investigate ihe role of SCD 1 in ihe prestrvati on of DNA, methylation patterns in p -cells, 
w e evaluated (lie; im pact of SCD1 deficiency on DN M T1, w hich is required fos m aintaining the DNA 
m ethylation profile [5 ]. We found that SCD1 knockdow n reduce d the level of D N M T1 protein by 
nearly  5 0%  in pancreatic islets com  pared w ith  W T islets (F igure 3A l. Both the im pairm ent of1 S C D l 
activity and downregulation of SCD1 gene expression ins INS-OE celis decreased DNMT1 p rotein levels 
by  approxim ayely 20°% and 35 0H, respectively  (Figure 3B ,C ). (N S-1E cells that w ere incubatyd w ith  
palm itate w ere characierized  by a ~55%  reduetion in D N M T1 protein level-. In groups of cells that 
w ere treated in  parallel w ith  the SCD1 inhibitor or s iR N A  against SCD1 and p alm itate, the protein 
content of DNM T1 decreared by  60-7001 com pared w ith control cells (F igure 3B,C-.
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Figure 3. DNA methyltransferase 1 (DNMT1) is downregulated in SCD1-deficient pancreatic islets and 
INS-1E cells. (A) DNMT1 protein levels in SCD1-/- pancreatic islets and WT islets. n = 6. * p < 0.05, 
vs. WT. (B,C) Western blot analysis of DNMT1 protein levels in INS-1E cells after SCD1 inhibition 
with A939572 (SCD1i) (B) or silencing of SCD1 gene expression by siRNA (siSCD1) (C) and palmitate 
(16:0) treatment. (D) Immunofluorescence staining of DNMT1 and quantitative analysis of DNMT1 
content in nuclei in INS-1E cells that were treated with the SCD1 inhibitor. The data are expressed as 
mean ± SD. Scale bar = 10 pm. * p < 0.05, ** p < 0.005, vs. vehicle/siCtrl; # p < 0.05, ## p < 0.005, vs. 16:0;
& p < 0.05, && p < 0.005, vs. siSCD1i; ~ p < 0.05, “  p < 0.005, vs. SCD1i+16:0.
To support the im m unoblot results, w e detected D N M T1 in IN S-1E cells w ith  the inhibition of 
SCD1 activity by im m unofluorescence staining. The visualization and quantification of fluorescently 
labeled D N M T1 indicated that SCD1 inhibition decreased D N M T1-positive staining in  cell nuclei, 
w hich was consistent with protein content (Figure 3D ). Treatment w ith palmitate enhanced the lowering 
effect of SCD1 dow nregulation on the fluorescence intensity  of D N M T1 (Figure 3D ). Additionally, 
consistent w ith previous reports [19,22], we observed a significant reduction in insulin-positive staining 
in SCD1-inhibited and palm itate-treated pancreatic p-cells (Figure 3D ).
2.4. Reduction in SCD1 Activity/Expression Leads to the Activation o fA M P K  and Increases SIRT1 Protein  
Expression in Pancreatic fi-Cells
To investigate the influence of SCD1 deficiency on the AMPK/SIRT1 axis in pancreatic islets in W T 
and SC D 1-/- m ice, w e m easured SIRT1 protein levels and the phosphorylation of A M PK  at Thr172, 
w hich is crucial for its activation [25]. Both A M PK  phosphorylation and SIRT1 protein levels w ere 
elevated m ore than tw o-fold in SC D 1-/- pancreatic islets com pared w ith W T islets (Figure 4A ,D).
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Figure 4. SCD1 regulates adenosine monophosphate-activated protein kinase (AMPK) and 
NAD-dependent deacetylase sirtuin-1 (SIRT1) in pancreatic islets and INS-1E cells. (A,D) Western blot 
analysis of AMPKphosphorylation at Thr172 (A) and the level of SIRT1 protein (D) in pancreatic islets 
from WT and SCD1-/- mice. n = 6. * p < 0.05, -vs. WT. (B,C,E,F) AMPK phosphorylation at Thr1e2 and 
SIRT1 protein levels in INS-1E cells that were treated with the SCD1 inhibitor A939572 (B,E) or siRNA 
against SCD1 (C,F) and palmitic acid (16:0). The data are expressed as mean ± SD of three independent 
experiments. * p < 0.0 5, ** p < 0.01, *** p < 0.001, vs. vehicletsiCtrl; # p < 0.05, ## p o  0.005 vs. 16: 0/16:0 
siCtrl; & p < 0.05, &&p < 0.005 vs. SCD1 i/siSCD1; ~ p < 0.05, vs. SCD1i/siSCD1+16 :0 .
A lm ost a three-fold  increase in A M PK  phosphorylation w as also observed in  IN S-1E cells that 
w ere treated w ith  the SCD1 inhibitor (Figure 4B ) and siRN A  against SCD1 (Figure 4C ) com pared 
w ith  control cells. In cells that w ere treated w ith  palm itate, A M PK  phosphorylation at Thr172 w as 
an average of m ore than four-fold higher com pared w ith  untreated cells. In SC D 1-deficient IN S-1E 
cells that w ere incubated w ith  palm itate, the extent of A M PK  phosphorylation increased nearly 
tw o-fold  com pared w ith  cells that w ere treated only w ith  the SCD1 inhibitor or siRN A  against 
SC D 1  (Figure 4B ,C). Furtherm ore, the inhibition of SC D 1  activity and dow nregulation of SC D 1  gene 
expression in INS-1E cells increased SIRT1 protein levels by approxim ately 80% and 50%, respectively 
(Figure 4E ,F). A n average 45%  increase in SIRT1 protein content w as observed in  IN S-1E cells that 
w ere stim ulated w ith  palm itate. H ow ever, no significant difference in  SIRT1 protein levels w as 
found betw een SC D 1-deficient IN S-1E cells and SC D 1-deficient IN S-1E cells that w ere treated w ith  
palm itate (Figure 4E,F).
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2.5. SCD1 Inhibition/D ownregulation Is Related to an Increase in the Deacetylation o fD N M T l by SIRT1
To investigate w hether the higher levels of SIRT1 protein in SC D 1-deficient IN S-1E cells are 
follow ed by higher deacetylase activity, w e m easured the level of histone H4 acetylation at lysine 16 
(H 4K16), w hich is directly associated w ith  and controlled by  SIRT1 [26,27] . In IN S-1E cells that w ere 
treated w ith the SCD1 inhibitor, H4K16 acetylation levels decreased by over 40% (Figure 5A ), whereas 
the dow nregulation of SCD1 gene expression decreased H 4K 16 acetylation levels by nearly  60% 
(Figure 5B ). Treatm ent w ith palm itate itself reduced the level of H4K16 acetylation by  approxim ately 
40% . Sim ilar to SIRT1 protein levels, no significant difference in the level of H 4K 16 acetylation w as 
observed betw een INS-1E cells that were treated w ith the SCD1 inhibitor or siRN A against SCD1 and 
SCD 1-deficient IN S-1E cells subjected to palm itate treatm ent (Figure 5A ,B).
Figure 5. Downregulationof SCD1 elevates SIRT1 activity in INS- 1E cells and promotes the deacetylation 
of DNMT1 lay 15IRT1. (A,B) Global acetyl histone H4K16 levels in INS-1E cells (indire ct indicator of 
SIRT1 deacetylase activity) after the pharmactlogkal inhibition of SCD1 (SCD1i) (A) or silencing of 
SCD1 gene expression (B) and palmitatr (16:0) treatment. The data are expressed as the mean ± SD 
of three independent experiments. * p < 0.05, ** p < 0.005, -vs. vehicle/siCtrl. (C) Mock precipitates 
(IgG control) and antiiSIRT1 immunoprecipitates from whole INS-1E cell lysates that were analyzed by 
Western blot using an antibody agamst IDNMT1. (D) Control and anti-DNMT1 immunoprecipitates 
from INS-1 E cells that were treated with the SCD1 inhibitor A129371 (SCD 1i) and palmitate ( 16:0) and 
immunoblotted with TIRT1 and anti-acutylated lysine (Ac-Lys) antibody.
To investigate w hether D N M T1 is a substrate of SIRT1 in  IN E-1E cells, w e perform ed 
co-im m unoprecipitation of thesr two proteins. The analysis showed that the antibody to endogenous 
SIRT1 coprecipitated endogenous DNM T1 (Figure 5C ) and vice versa (Figure 5D ). In control sam ples 
that did not contain specific antibodies against SIRT1 or DN M T1, the precipitation of neither DNMT1 
(Figure 5C ) nor SIRT1 (Figure 5D ) w as detected. We also measured the level of DNMT1 acetylatien by 
blotting m ock precipitates (IgG control) and anti-DNM T1 precipitates w ith anti-acetyl lysine antibody. 
We found th a i D N M T1 u nderw ent hyp oactty lation  in  SC D 1-inhibited  IN S-1E cells (Figure 5D ) . 
In sam ples ihat w ere intubated w ith palm itate itsel f, the l eve l of DNMT1 acetylation was greater than 
in untreaTed cellu, but the application of palmitate did not elevate DNMT1 acetylation in SCD1-deficient 
IN S-1E cells. In both  precipitates of IN S-1E cells that w ere treated witU the SCD1 inhibitor and
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palm itate, w e also detected a higher level o f SIRT1 protein than in sam ples that w ere n ot incubated 
w ith the SCD1 inhibitor and palm itate (Figure 5D ).
2.6. Inhibition o fA M P K  Upregulates DNM T1 in fi-Cells and Partially Restores the Level ofgD N A  
M ethylation under Conditions o f  SCD 1 Depletion
To test the hypothesis that alterations of the induction of DNM T1-dependent gD N A  m ethylation 
that is caused by SCD1 inhibition rely on AMPK/SITR1 axis stimulation in p-cells, we pharmacologically 
blocked AM PK activity with compound c. The inhibition of AM PK by compound c w as accompanied 
by  a decrease in SIRT1 protein levels in SCD 1-deficient and palm itate-treated cells (Figure 6 A ,B).
Figure 6. Inhibition of AMPK in SCD1-deficient INS-1E cells increases DNMT1 protein levels and 
prevents gDNA hypomethylation under conditionn of SCD1 deficiency. (A,B) DNMT1 levels in INS-1E 
cells that: weie co-treated with the SCD1 inhibitor A939572 (SCDli) (A), siSCD1 (B), palmitic acid (16:0), 
and 10 pM chmpound c to block AMPK. The levels of AMPK phosphorylation at Thr172 (pAMPK Thr172) 
and SIRT1 and DNMT1 protein content were measured by Western blot. (C,D) Effect of AMPK inhibition 
by compound c on gDNA methylation levels in INS-1E cells with the inhibition of SCD1 activity (C) and 
SCD1 gene silencing (siSCD1) (ID). * p < 0.05, vs. VehicleisiCtrl; ~ p < 0.05, vs. 16:0/16:0+siCtrl, & p < 0.05, 
&& p < 0.005, -vs. siSCD1/SCD1i; #p<0.05,## p < 0.005, -vs. SCD1iisiSCD1+16:0. The data are expressed 
as the mean ± SD of three independent experiments. AMPK: adenosine monophosphate-activated 
protein kinase; SIRT1: NAD-dependent deacetylase sirtuin-1.
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Furtherm ore, the inhibition of A M PK  substantially  increased D N M T1 protein levels in  IN S-1E 
cells that were incubated w ith palmitate and the SCD1 inhibitor (Figure 6 A ) or the siRNA against SCD1 
(Figure 6 B) com pared w ith  cells that w ere not treated w ith  com pound c. Interestingly, the inhibition 
of A M PK  by com pound c protected against gD N A  hypom ethylation in  SC D 1-deficient IN S-1E 
cells (Figure 6 C ,D). M oreover, the effect of A M PK  inhibition on the level of gD N A  m ethylation 
under conditions of SCD1 deficiency w as m ore pronounced in cells that w ere treated w ith palm itate 
(Figure 6 C ,D). In  groups of cells that w ere treated w ith  both the SCD1 inhibitor or siRN A  against 
SCD1 and com pound c, the decrease in  gD N A  m ethylation levels w as ~25%  low er than in cells that 
w ere incubated only w ith the SCD1 inhibitor or siRN A (Figure 6 C,D). Additionally, the application of 
com pound c increased the level of gD N A  m ethylation by  ~40%  in SC D 1-deficient IN S-1E cells that 
w ere stim ulated w ith  palm itate, com pared w ith  the group of SC D 1-deficient IN S-1E cells incubated 
w ith palm itate but untreated w ith com pound c (Figure 6 C ,D).
3. D iscussion
Epigenetic alterations, such as D N A  m ethylation, link  adaptive gene expression profiles to 
environmental stimuli during the progression of diabetes [2,3 ]. Hyperlipidemia is a primary metabolic 
stressor that is associated w ith T2D. p-cells are extremely susceptible to high lipid levels and subsequent 
lipotoxicity. Several studies have reported that the m ethylation status of key loci of p-cell function 
(e.g., the INS gene that encodes insulin [28]), can be altered in the T2D in response to lipotoxicity [13,14,29,30]. 
Elucidation of the molecular m echanisms that m ediate the interaction between environmental exposure 
and gene expression and the preservation of p-cell function under lipotoxic conditions is a key priority 
for T2D  m anagem ent. In  the present study, w e found that SC D 1, a lipogenic enzym e that protects 
p-cells against lipotoxicity  [15,16], is an essential com p onent of the ep igenetic regulatory netw ork 
in p-cells. W e found that SCD1 activity  is required for m aintaining D N A  m ethylation patterns and 
chromosomes in pancreatic p-cells. We also revealed a m echanism by w hich SCD1 may control gDNA 
m ethylation, w hich  is based on the dependence of D N M T1 regulation on activation of the energy 
sensors A M PK and SIRT1.
The low er activity  and expression of SCD1 are related to an  oversupply o f SFAs to M UFAs 
and thus lipotoxicity, w hich  contributes to p-cell failure and T2D  progression [19,31]. The fatty 
acid-induced effect on p-cells depends on both  level of fatty acid desaturation and tim e of exposure 
hence SCD1 is a m ain brake on palm itate toxicity  in  p-cells [32,33]. The overexpression of SCD1 
prevents palmitate-induced endoplasmic reticulum stress and apoptosis in several cell types, including 
M IN 6  p-cells and hum an pancreatic islets [32,34,35]. In addition, activation of liver X receptor (LXR), 
retinoid X receptor (RXR) or peroxisom e proliferator-activated receptor a  (PPARa) in p-cells induced 
the expression of SCD1, w hich has also been shown to protect against palm itate-induced toxicity [36]. 
In contrast, inhibition of SCD1 activity  negatively  affected the autophagy outcom e and ER  stress 
response, and led to the p-cell dem ise [19] . M ice lacking SCD1 in the BTBR leptin ob/ob background 
exhibited decline in a glucose-stim ulated insulin secretion and a subpool of p-cells displayed hallmarks 
of SFA-induced lipotoxicity [15]. Furtherm ore, there w as a significant increase in the expression level 
of SCD1 transcript in islets of prediabetic 6  w eek old ZD F rats in com parison to islets of 12 w eek 
old rodents w ith  onset of overt diabetes [34]. N otew orthy, palm itate enhances som e of the effects 
of SCD1 deficiency in p-cells [22,37]. Furtherm ore, since oleate can overcom e som e of the effects of 
SCD1 deficiency in hepatocytes [38], and given the im portant role of oleate in  regulation of p-cell 
function [39], it is possible that the effects of SCD1 deficiency in  p-cells m ay be m ediated by  oleate. 
However, m ore studies are needed to address this issue.
In  the present study, w e found that SCD1 downregulation/inhibition resulted in  the global 
hypom ethylation of D N A  in pancreatic islets and the IN S-1E p-cell line and changes in  spatial 
distribution of m ethyl groups w ithin single chrom osom e 1. O bservations of global DNA m ethylation 
levels w ere m ade using classical electrophoresis and D N A  cleavage by restriction enzym es, and they 
w ere com plem ented  by R am an spectroscopy. V ibrational spectroscopy is a novel tool for D N A
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m ethylation studies and it w as chosen by  us because of its ability  to analyze the m olecular and 
chem ical structure of D N A  and chrom osom es. R am an spectroscopy is a label-free, non-invasive and 
m arker-independent m ethod [40,41]. The undeniable advantage of Ram an spectroscopy is the ability 
to obtain  com plete chem ical inform ation in one spectrum , w hich  enables sim ultaneous analysis of 
the chem ical structure of proteins, D N A , lipids, carbohydrates, and other m olecules in the studied 
sam ple [40]. W hat is m ore, it gives access to inform ation on the secondary structure of proteins 
or D N A  conform ation based on  the position of characteristic R am an bands. W hen com bined w ith  
m icroscopy, it also enables one to follow  the distribution of chosen chem ical com ponents in single 
cells or chrom osom es w ith  the subm icron spatial resolution. H ow ever, there are som e lim itations. 
Ram an spectroscopy is not yet a well-established method for DNA m ethylation analysis [40]. Observed 
Ram an bands of such complicated samples as chromosomes, cells or tissues are a sum of contributions 
from  vibrations o f various m olecules at different conform ations, w hich m akes analysis advanced, 
and usually, a com bination of R am an spectroscopy and m ultivariate statistical analysis is required 
to interpret the obtained results [40,41]. W h at is m ore, the pre-processing of spectra and different 
approaches applied in the analysis could have an im pact on the final results. Som e non-linear effects 
in R am an spectroscopy, such as resonances in  hem oproteins and self-absorption of sam ples, could 
influence band intensities and yet influence the quantitative analysis of sam ples [42].
The administration of palmitate under conditions of SCD1 deficiency enhanced the lowering effect 
of SCD1 ablation on gD N A  m ethylation, supporting previous studies that reported that the effects 
of palm itate toxicity w ere augm ented by SCD1 depletion in p-cells [22,34]. The treatm ent of IN S-1E 
cells with palm itate itself slightly, but non-significantly, decreased gDNA m ethylation levels under the 
present experim ental conditions. The im pact of palm itate on genom e-w ide m R N A  expression and 
DNA methylation patterns in hum an pancreatic islets was studied in detail by Hall et al. Similar to the 
present results, H all et al. show ed that the exposure of hum an pancreatic islets to palm itate has only 
m inor effects on gD N A  m ethylation levels in pancreatic islets [14]. Interestingly, a high proportion 
of hypom ethylation of C pG  sites, especially  C pG s in  regulatory sequences of the genes, relative to 
hyperm ethylation events w as observed in diabetic islets [29,30] . These findings suggest that som e of 
the changes in m ethylation that w ere observed in SCD1-deficient islets and IN S-1E cells, m ay overlap 
w ith m ethylation aberrations that are characteristic of T2D.
In our previous study, we found that SCD1 was a potent regulator of adipocyte and white adipose 
tissue inflam m ation that governs the expression of inflam m atory cytokines via changes in  prom oter 
m ethylation [21]. Interestingly, in  3T3-L1 adipocytes, SCD1 inhibition/gene silencing resulted in 
gD N A  hyperm ethylation, and this phenom enon w as not associated w ith  expression of the D N A  
m ethyltransferases D N M T1, D N M T3a, or D N M T3b [21] . In contrast, in pancreatic islets and IN S-1E 
cells, the decrease in gD N A  m ethylation that w as related to SCD1 deficiency corresponded to low er 
D N M T1 protein levels. D N M T1, in addition to its m ethyltransferase activity, is also involved in 
controlling cell cycle progression [10,43,44]. A recent study showed that the tissue-specific upregulation 
of DNM T1 in pancreatic p-cells increased their proliferation ability [43]. Thus, the downregulation of 
D N M T1 m ay be associated w ith  a decrease in the level of gD N A  m ethylation and a decrease in  the 
proliferation rate of IN S-1E cells that are treated w ith  the SCD1 inhibitor and palm itate, w hich  w as 
previously dem onstrated [19] . The opposite effects of SCD1 ablation on gD N A  m ethylation levels in 
p-cells and adipocytes suggest that the mode of the regulation of DNA methylation by SCD1 is specific 
to certain tissues and may differ betw een p-cells and insulin-sensitive tissues. The divergent im pact of 
SCD1 inhibition in T2D -relevant tissues has been  w idely  recognized. The accum ulation of SFAs by 
SCD1 inhibition can promote inflammation and pancreatic p-cell failure [15,17,18,45]. The knockdown 
of SCD1 protects against diet-induced obesity and hepatic steatosis. SCD1 deficiency in skeletal muscle 
and adipose tissue increases the rate of fatty  acids (FA) p -oxidation and glucose utilization, thereby 
im proving insulin sensitivity and basal m etabolic rate [46,47].
To date, several studies have shown that SCD1 deficiency triggers activation of the AM PK signaling 
pathw ay in the liver [48], skeletal m uscles [20], and cancer cell lines [49,50]. The A M PK -m ediated
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actions of SCD1 also include autophagy-dependent cell growth and death [49,50], FA p-oxidation [48], 
and histone acetylation [20]. Consistent w ith previous studies of other tissues, w e found that the loss of 
SCD1 expression activated AM PK in pancreatic islets and IN S-1E cells. In accordance w ith a study of 
isolated rat islets and M IN 6  cells [51], we found that palmitate treatm ent lead to the activation of AMPK 
in IN S-1E p-cells. Furtherm ore, A M PK  activation enhanced SIRT1 protein expression and activity 
under the present experim ental conditions, w hich is consistent w ith  previous studies that described 
reciprocal interactions and the interdependence of these tw o m etabolic sensors [20,52,53]. How ever, 
the molecular m echanism  of the SCD1-dependent control of DNA methylation is still unknown. Given 
that the AMPK/SIRT1 axis mediates some effects of SCD1 deficiency in insulin-sensitive tissues [20,48], 
further characterization of the roles of A M PK  and SIRT1 in the regulation of D N A  m ethylation in 
SCD1-deficient p-cells is an attractive area of investigation. Palmitate can also influence the acetylation 
of m ultiple proteins in clonal p-cells [54]. We found that SIRT 1  interacted w ith D N M T 1  in pancreatic 
p-cells and m ediated m ore intensive D N M T1 deacetylation in  cells that w ere treated w ith  the SCD1 
inhibitor compared with control cells. In contrast to SCD1 inhibition, treatm ent w ith palmitate did not 
decrease the level of D N M T1 acetylation in IN S-1E cells. Therefore, the opposing acetylation status 
of D N M T1 in  IN S-1E cells that w ere incubated w ith  the SCD1 inhibitor, relative to IN S-1E cells that 
w ere stim ulated w ith  palm itate, m ay be related to the differential regulation of D N M T1 activity and 
m ay explain m ore severe changes in gD N A  levels in SC D 1-deficient cells. However, considering the 
divergent effect of single lysine deacetylation on DNMT1 function and the fact that SIRT1 is not the only 
DNM T1 deacetylase [9,10], further research is needed to precisely verify the role of SIRT1-dependent 
DNM T1 deacetylation on m ethyltransferase activity in palm itate-treated p-cells.
Lastly, w e investigated w hether activation of the AMPK/SIRT1 signaling cascade m ediates the 
influence of SCD1 on D N A  m ethylation in pancreatic p-cells. R ecent studies suggest that m etabolic 
state can directly influence D N A  m ethylation via the ability  of A M PK  to phosphorylate epigenetic 
m odifying enzym es, such as D N M T1 [55] and TET2 dioxygenase [56]. Studies of cancer cell lines 
showed that AM PK regulates gDNA m ethylation by affecting the availability of a methyl group donor 
that is required for DNM Ts [57]. Furtherm ore, the A M PK-m ediated inhibition of transcription factor 
Sp1, resulted in low er levels of D N M T1 gene transcription [58] . Interestingly, w e found that A M PK  
inhibition resulted in a decrease in SIRT1 protein levels, an increase in DNM T1 protein levels, and an 
increase in gDN A m ethylation levels in SCD 1-defcient IN S-1E cells. The present results indicate that 
the m aintenance of D N A  m ethylation patterns in pancreatic p -cells m ay be regulated by SCD1 in 
an AM PK/SIRT1-dependent m anner through the regulation of D N M T1. The proposed m olecular 
m echanism  that is involved in the SC D 1-dependent control of D N A  m ethylation in IN S-1E cells, 
w hich requires the coordinated activation of A M PK and SIRT1, is presented in Figure 7 .
Altogether, the present results indicate that SCD1 controls DNA methylation patterns in pancreatic 
islets and p-cells. Our findings uncover a novel pathway w hereby SCD1 dynam ically regulates DNA 
m ethylation in pancreatic islets and controls D N M T1 through the AMPK/SIRT1 axis. O ur findings 
provide additional mechanistic insights into the role of SCD1 in maintaining DNA m ethylation patterns 
in p -cells in response to lipotoxicity  and diabetes progression. The current study sheds light on the 
m echanism s that regulate the epigenom e in pancreatic p-cells. The elucidation of such m echanism s is 
crucial for the design of T2D treatm ent approaches that can circum vent epigenetic barriers.
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Figure 7. Impact of SCD1 deficiency on gDNA methylation levels in pancreatic p-cells. SCD1 
downregulation in INS-1E cells results in the activation of AMPK, upregulation of SIRT1, and promotion 
of DNMT1 deacetylation. AMPK activation and SIRT1-dependent changes in DNMT1 acetylation status 
trigger the loss of DNMT1 function and stability, consequently leading to gDNA hypomethylation.
The dashed arrow indicates the potential direct (independent of SIRT1) control of gDNA methylation 
levels by AMPK.
4. M aterials and M ethods
4.1. A nim als and Pancreatic Islet Isolation
The generation of SC D 1-/- knockou t m ice w as previously  described [59]. M ale w ildtype (W T) 
C57/BL6 and SCD1-/- mice on a B 6  background (10 w eeks of age, n = 6 ) were fed a standard laboratory 
chow  d iet (Sniff, G erm any) and w ater ad libitum . The m ice w ere sacrificed by cervical dislocation, 
and pancreatic islets w ere isolated via intraductal infusion. Briefly, the pancreas w as perfused by 
in jecting 5 m L of ice-cold collagenase (Sigm a, St. Louis, M O , USA ) solution in H ank's Balanced Salt 
Solution (HBSS) into the clam ped pancreatic duct. Once inflated and rem oved, pancreatic tissue w as 
incubated in 3 mL of collagenase/HBSS at 37 °C in a water bath for 10-15 min to digest exocrine tissue. 
Digested tissue was then w ashed twice w ith HBSS and collected in a 70 pm cell strainer. The pancreatic 
islets w ere separated from  rem aining tissue by  density  centrifugation in a histopaque-1077 (Sigm a) 
gradient. The histopaque w as then rem oved from  the islet suspension by  a series of rinses in  H BSS. 
Islets w ere then handpicked using a stereom icroscope and stored a t - 8 0  °C  for further analyses. 
A ll protocols used in this study w ere approved by the F irst Local E thical C om m ittee for A nim al 
Experim ents in W arsaw (Perm it num ber: 37/2016, approved 21/01/2016).
4.2. M aterials
The prim ary antibodies w ere obtained from  the follow ing suppliers: SCD1 (catalog no. 2283, 
Cell Signaling Technology, H ertfordshire, U K ), phosphorylated A M P K a (pA M PK ; catalog no. 2531, 
Cell Signaling Technology, Hertfordshire, U K), DNM T1 (catalog no. 5032, Cell Signaling Technology, 
Hertfordshire, UK), D N M T1-C hiP Grade (catalog no. ab13537, Abcam , C am bridge, UK), AMPKa1/2 
(catalog no. sc-25792, Santa C ruz Biotechnology, Santa C ruz, C A , U SA ), acetyl-lysine (catalog no.
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N B100-74339, Novus Biologicals, A bingdon, UK), SIRT1 (catalog no. 07-131, M illipore, Billerica, MA, 
U SA ), and p-actin (catalog no. 3854, Sigm a, St. Louis, M O, USA ). Secondary peroxidase-conjugated 
goat anti-rabbit IgG  (catalog no. 67437) and goat anti-m ouse IgG  (catalog no. 115-035-146) w ere 
obtained from MP Biom edicals (Irvine, CA, USA) and Jackson Im m unoReasearch Laboratories (West 
Grove, PA, USA), respectively. Secondary antibodies conjugated to Alexa Fluor-488 and Alexa Fluor-568 
w ere purchased from  Invitrogen (C arlsbad, C A , U SA ). The other chem icals w ere purchased from  
Sigm a unless otherw ise specified.
4.3. INS-1E Cell Culture and Chronic Treatments
IN S-1E cells (rat insulin-secreting pancreatic p-cell line) w ere a generous g ift from  Dr. Pierre 
M aechler (U niversity of G eneva, G eneva, Sw itzerland). The cells w ere cultured in com plete RPM I 
m edium  supplem ented w ith 5% heat-inactivated fetal bovine serum , 1 mM  sodium  pyruvate, 10 mM 
HEPES, 2 mM glutamine, 50 pM 2-m ercaptoethanol, 100 IU/mL penicillin, and 100 pg/mL streptomycin 
and maintained in a 5%  CO 2  atmosphere at 37 °C. To inhibit SCD1 activity, the cells were preincubated 
w ith  2 pM of the SCD1 inhibitor A 939572 (Biofine International, Blain, W A, U SA ) for 4 h and then 
co-supplem ented w ith 0.4 m M  bovine serum  album in (BSA )-conjugated palm itic acid for 16 h. As an 
indicator of SCD1 activity, w e m easured desaturation ratios of palm itate (16:0) and stearate (18:0), 
w hich are preferred substrates of SCD1, as described previously [19]. To silence SCD1 expression, INS-1E 
cells w ere grown for 24 h in antibiotic-free m edia and reverse-transfected w ith 60 ng of siRN A (given 
am ount w as used for transfection of 1 X 106  cells in one w ell of a 6 -w ell plate) against SCD1 (catalog 
no. s73339, A m bion, H ouston, TX, U SA ) for 72 h  using Lipofectam ine 2000 (0.5 pL/cm2; Invitrogen). 
Silencer negative control #1 siRNA (Ambion) was applied as a negative control. The silencing efficiency 
w as m easured 72 h after transfection using real-tim e PC R  and W estern blot. Palm itate w as added for 
the last 16 h before sam ple collection. To inhibit A M PK  before SCD1 inhibition or SCD1 silencing, 
the cells w ere preincubated for 1 h w ith  10 pM com pound c (Sigm a) and treated w ith  com pound 
c throughout the entire procedure. As a vehicle control for palm itate, IN S-1E cells w ere grow n in 
m edium  that w as supplem ented w ith  7.5%  BSA. D im ethyl sulfoxide (DM SO ) w as used as a vehicle 
control for the SCD1 inhibitor and com pound c.
4.4. DNA Extraction and Global DNA M ethylation Assessm ent
D N A  w as extracted u sing the D N easy Blood and Tissue K it (Q iagen, G erm antow n, M D, USA ) 
according to the m anu factu rer's instructions. The global D N A  (gD N A ) m ethylation profile w as 
determ ined using the EpiJet G lobal M ethylation k it (Therm o Scientific, W altham , M A, USA ). Briefly, 
to cleave gDNA, an isoschizomeric pair of restriction enzymes (MspI/HpaII) was used. M spI and HpaII 
restriction enzym es are characterized by  different sensitivities to C pG  m ethylation. W hen  cytosine 
m ethylation w ithin the 5'-C C G G -3' internal CpG tetranucleotide sequence occurs, cleavage with HpaII 
is blocked. O therw ise, cleavage w ith M spI is unaffected. The cleavage results w ere visualized on 1% 
agarose gel. The effect of SCD1 inhibition on gD N A  m ethylation levels w as also assessed by  Ram an 
spectroscopy as described below.
4.5. Isolation o f  M etaphase Chromosomes
M etaphase chrom osom es from  IN S-1E cells w ere obtained u sing classic cytogenetic m ethods. 
To arrest cells in m etaphase, 5%  colcemid (Max Karyo Colcemid Solution, Thermo Scientific) was added 
to the grow th m edium . A fter 2 h  of incubation, the cells w ere rinsed tw ice w ith  phosphate-buffered 
saline (PBS) and trypsinized. The collected cells were incubated w ith 0.75 mM  KCl, fixed in a mixture 
of glacial acetic acid and m ethanol (1:3), and deposited onto C aF 2  w indow s (C rystran, IR  grade, 
0  20 mm). Sam ples w ere air dried before Ram an m easurem ents.
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4.6. Raman Spectroscopic M easurem ents o f  Chromosomes and DNA M ethylation
The quality  of m etaphases and single chrom osom es w ere assessed before spectroscopic R am an 
m easurem ents using an A FM  m icroscope (N T-M DT) in non-contact m ode (NSG01 Si probes). Based 
on the A FM  topographical analysis of the obtained m etaphases, the first pair of chrom osom es w as 
chosen from each metaphase for further Raman investigation. Single chromosome no. 1 was identified 
in m etaphases based on their size and m orphology. Spectroscopic R am an m easurem ents of single 
chromosomes were performed using an integrated A FM -Ram an (NT-MDT-Renishaw) system. Raman 
m aps w ere obtained u sing an inVia R enishaw  spectrom eter that w as equipped w ith  an EM C C D  
detector (Back Illuminated, Deep Depletion CCD, Rapide 1600 X 200) with a Leica confocal microscope 
(100x magnification, N A = 0.85). Raman maps were collected using a green 532 nm edge laser (regular 
mode, m axim um  power = 3 mW, grating = 1800 L/mm) w ith a pixel size of 0.5 X 0.5 pm. Furthermore, 
using the sam e setup, droplets of gD N A  solution from IN S-1E cells were measured and considered as 
reference data. D uring the experim ents, Ram an spectra of D N A  and chrom osom es w ere analyzed in 
the spectral range of 3200-800 cm -1 .
The A FM  topographic im ages w ere analyzed using SPIP softw are (Im age M etrology, Lyngby, 
D enm ark). D N A  and chrom osom e spectra w ere analyzed using W IR E 4.2 softw are (Renishaw ). 
Cosmic rays were first removed based on the N earest Neighbor algorithm, and baseline was subtracted 
using the Intelligent fitting algorithm . Subsequently, spectra w ere sm oothed (Savitzky-Golay, 11 pt, 
2nd order), and Em pty M odeling (Em pty m odelling™ , W iRE 4.2 softw are, Renishaw , UK) analysis 
w as perform ed on R am an chrom osom e m aps, w hich  allow ed us to obtain  spectra of chrom osom es 
and substrates w ith  cellular debris. Em pty m odelling  is a chem om etric m ethod, w hich  enables the 
extraction of spectra of the key com ponents from the Ram an map. The algorithm  starts from an initial 
estim ation that the spectral values of a first com ponent of the sample are all equal, w hich is an "em pty 
m odel" assumption and then resolves that component. In the next steps, the algorithm successively and 
iteratively resolves other components based on already resolved spectra. In our analysis, it w as used to 
avoid the influence of cellular contamination. The resulting substrate spectrum, obtained using empty 
m odelling, w as subtracted from  each spectrum  of the R am an m ap w ith  the appropriate coefficient 
by  resetting the characteristic bands for the substrate. A fterw ard, a spatial d istribution of the D N A , 
proteins (m ainly histones), and -C H 3  groups w as calcu lated  u sing O riginPro 2017 (O riginLab) and 
Gwyddion 2.41 software (Czech M etrology Institute). The distribution was calculated as the integral of 
the band characteristic for the stretching of bonds betw een phosphate and oxygen atom s in the D N A 
backbone in  the spectral range of 1280-1215 cm -1 , the band characteristic for am ide I in  the spectral 
range of 1695-1630 cm -1 , and the band characteristic for -CH 3  group stretching in the spectral range of 
2 900-2850  cm -1 . Subsequently, O PU S 7.5 softw are (Bruker) w as used for u nit vector norm alization 
(in the spectral range of 1750-1030 cm -1 ) of spectra that w ere collected from chrom osom es and DNA 
solutions. An estimation of global m ethylation level in gDNA and chromosomes was performed based 
on the integral calculation of the band characteristic for v ibrations o f -C H 3  groups in the spectral 
range of 2910-2870 cm - 1  and 2900-2850 cm -1 , respectively. O btained results w ere norm alized to the 
integral of the band characteristic for vibrations o f PO 2 -  groups of D N A  backbone in the spectral 
range of 1110-1030 cm - 1  in case of DNA solutions and in the spectral range of 1110-1070 cm - 1  in case 
of chrom osom es.
4.7. INS-1E Im m unostaining
INS-1E cells were grown on 0.001% poly-L-ornithine-coated coverslips in 24-well plates. The cells 
w ere w ashed w ith  PBS and fixed w ith 4%  paraform aldehyde for 15 m in at room  tem perature. Fixed 
cells w ere then perm eabilized w ith  0.2%  Triton X-100 for 30 m in, rinsed w ith  PBS, and blocked w ith 
buffer that consisted of 3%  BSA  in  PBS for 1 h. To obtain  dual im m unostaining, prim ary antibodies 
for D N M T1 (A lexa 488) and insulin  (A lexa 568) w ere co-incubated in  blocking buffer overnight. 
The next day, the cells w ere w ashed three tim es in PBS and exposed to appropriate fluorescently 
labeled secondary antibody for 1  h. A fter additional rinses w ith  PBS, the cells w ere co-stained w ith
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4',6-diam idino-2-phenylindole (DAPI) to identify nuclei. Fluorescence im ages w ere acquired using a 
Zeiss spinning disk confocal m icroscope and then analyzed using Im ageJ software.
4.8. Co-Imm unoprecipitation A ssay
IN S-1E cells w ere hom ogenized in precipitation lysis buffer (20 m M  Tris (pH  8.0), 75 m M  N aCl, 
15 mM M gCl2 , 1 mM ethylenediam inetetraacetic acid (EDTA), 0.5% N onidet P -4 0 ,10% glycerol, 5 pg/mL 
pepstatin A, 10 pg/mL leupeptin, and 1.4 pg/mL aprotinine). H om ogenates that contained 500 pg of 
proteins were incubated overnight at 4 °C w ith 20 pL of pre-washed protein A/G PLUS-agarose beads 
(Santa Cruz Biotechnology) and 1 pg of SIRT1 or DNM T1 (Abcam) antibodies or IgG alone (negative 
control sam ples). The im m unoprecipitations w ere w ashed six tim es w ith  precipitation lysis buffer, 
resuspended in electrophoresis sam ple buffer, and boiled for 10 m in at 95 °C. The aliquots w ere then 
analyzed by W estern blot using an antibody against acetylated lysine (AcLys).
4.9. Quantification o f  Global Acetylation o fH iston e H 4K16
IN S-1E cells (1 X 107) w ere harvested and lysed on ice in 1 mL of TEB buffer (PBS that contained 
0.5% Triton X -100 ,2 mM phenylmethylsulfonyl fluoride (PMSF), and 0.02% N aN 3 ). After lysis, histone 
core proteins w ere obtained from the rem aining cell pellet by  acidic extraction w ith 0.5 N  H Cl + 10% 
glycerol on ice for 30 m in. Subsequently, probes w ere centrifuged at 12,000 rotations per m inute for 
5 min at 4 °C, and the supernatant fraction w as collected. Histone core proteins were then precipitated 
from  the supernatant fraction w ith  acetone a t - 2 0  °C  overnight. Extracted core histone pellets w ere 
air-dried and dissolved in high-perform ance liquid chromatography-grade distilled w ater and stored at 
- 8 0  °C. The level of histone H4 acetylation at lysine 16 was colorim etrically detected using the EpiQuik 
Global Acetyl H istone H4K16 Quantification Kit (Epigentek, Farm ingdale, NY, USA) according to the 
m anufacturer's instructions.
4.10. Gene Expression Analysis
For real-tim e reverse-transcription polym erase chain reaction (RT-PCR), RNA w as isolated from 
the experim ental sam ples using the Total RN A  M ini Plus Concentrator (A&A Biotechnology, G dynia, 
Poland) according to the m anufacturer's protocol. DNase-treated RNA was reverse-transcribed using 
the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific). To evaluate SCD1 m RNA expression 
levels, optimized primers that targeted the Scd1 gene (5'-ACATTCAATCTCGGGAGAACA-3' (forward) 
and 5 '-C C A TG C A G TC G A TG A A G A A C -3' (reverse)) w ere used. R eal-tim e quantitative PC R  w as 
performed using the RT-PCR 7900 HT Real Time PCR System , and SYBR green was used for detection. 
The relative expression of each sam ple w as determ ined after norm alization to G A PD H  u sing the 
AACt m ethod.
4.11. Western Blot A nalysis
The experimental samples were collected and lysed for 30 min in ice-cold buffer (50 mM Tris-HCl, 
5 m M  EDTA, 1% Triton X -1 0 0 ,10 m M  sodium  fluoride, and 150 m M  NaCl) that contained inhibitors 
of proteases and phosphatases (10 pg/pL leupeptin , 5  pg/pL pepstatin  A , 2  pg/pL aprotinine, 1  m M  
sodium  orthovanadate, and 1  m M  PM SF). The protein content in the lysates w as determ ined using a 
protein assay (Bio-Rad, H ercules, C A , U SA ) w ith  BSA  as the reference. The prepared sam ples w ere 
loaded onto 10% sodium  dodecyl su lfate-polyacrylam ide gel electrophoresis gels. The separated 
proteins were then transferred to PVDF m em branes (Millipore, Billerica, M A, USA) and blotted using 
appropriate antibodies. Proteins w ere visualized using SuperSignal W est Pico PLUS Chem ilum inescent 
Substrate (Thermo Scientific) and quantified by densitometry.
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4.12. Statistical Analysis
Statistical significance w as assessed using GraphPad Prism 8.3.0 software. M ultiple com parisons 
w ere perform ed u sing one-w ay analysis of variance (ANOVA) follow ed by  Tukey's p ost hoc test. 
U npaired t-tests w ere used w hen tw o groups w ere com pared. Values of p  <  0.05 w ere considered 
statistically significant. The data are expressed as m ean ± SD.
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AFM Atomic force microscopy
AMPK AMP-activated protein kinase
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